Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 2199-2201, 1997;
This Article
Right arrow Full Text
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gudmundsson, A.
Right arrow Articles by Carnes, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gudmundsson, A.
Right arrow Articles by Carnes, M.
Related Collections
Right arrow Laboratory Management
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1997;43:2199-2201.)
© 1997 American Association for Clinical Chemistry, Inc.


Technical Briefs

Serum Concentrations of Interleukin-6 Are Increased When Sampled Through an Indwelling Venous Catheter

Adalsteinn Gudmundssona, William B. Ershler, Brian Goodman, Stephanie J. Lent, Steven Barczi and Molly Carnes

Dept. of Med., Univ. of Wisconsin-Madison, 600 Highland Ave., Madison, WI 53792, and Geriatric Res., Education and Clin. Center, William S. Middleton Memorial VA Hosp., 2500 Overlook Terrace, Madison, WI 53705
a address correspondence to this author, at Middleton Veterans Hospital: fax 608-262-7648, e-mail agudmund@facstaff.wisc.edu

Circadian and ultradian variation is a prominent feature of most endogenous biodynamic processes and has been extensively studied in neuroendocrine systems (1). Interleukin-6 (IL-6) is a multifunctional cytokine that plays an important role in many age-related diseases, including postmenopausal osteoporosis (2)(3). Estrogen has been shown to directly inhibit IL-6 production (4)(5). Very little information on the circadian rhythms and no information on ultradian rhythms of IL-6 or other pro-inflammatory cytokines exists. Recent research has demonstrated a strong reciprocal interaction between IL-6 and the hypothalamic–pituitary–adrenal (HPA) axis (6)(7). Specifically, recombinant IL-6 has been shown to stimulate the HPA axis in humans (8). The recent availability of highly sensitive assays for measuring IL-6 provides the opportunity to study the rhythmic pattern of this cytokine. A study in men, in which samples were collected every 3 h by direct venipuncture, showed a large circadian variation in circulating IL-6 with a peak at 0100 and a nadir at 1000 (9). More frequent sampling is required to elucidate ultradian fluctuations, which typically have periods of 60 to 90 min (10).

For practical reasons, indwelling venous catheters rather than direct venipunctures have been used for studying frequently sampled time series. We designed a study, using an indwelling venous catheter for continuous integrated 15-min sample collection, to establish the normal variations of circulating IL-6 over 24 h in healthy postmenopausal women, and to assess the effect of estrogen replacement therapy on these patterns. In studying the first subject, it became apparent that serum IL-6 reached higher values than expected. Here, we demonstrate that an indwelling peripheral venous catheter leads to local tissue production of IL-6. We also demonstrate that this local production of IL-6 does not affect . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
Ann Rheum DisHome page
M G Perry, J R Kirwan, D S Jessop, and L P Hunt
Overnight variations in cortisol, interleukin 6, tumour necrosis factor {alpha} and other cytokines in people with rheumatoid arthritis
Ann Rheum Dis, January 1, 2009; 68(1): 63 - 68.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
I. Liuba, H. Ahlmroth, L. Jonasson, A. Englund, A. Jonsson, K. Safstrom, and H. Walfridsson
Source of inflammatory markers in patients with atrial fibrillation
Europace, July 1, 2008; 10(7): 848 - 853.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Mohlig, M. Freudenberg, T. Bobbert, M. Ristow, H. Rochlitz, M. O. Weickert, A. F. H. Pfeiffer, and J. Spranger
Acetylsalicylic Acid Improves Lipid-Induced Insulin Resistance in Healthy Men
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 964 - 967.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. K. Kiecolt-Glaser, T. J. Loving, J. R. Stowell, W. B. Malarkey, S. Lemeshow, S. L. Dickinson, and R. Glaser
Hostile Marital Interactions, Proinflammatory Cytokine Production, and Wound Healing
Arch Gen Psychiatry, December 1, 2005; 62(12): 1377 - 1384.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. H. Halpern, M. B. Sholar, J. Glowacki, N. K. Mello, J. H. Mendelson, and A. J. Siegel
Diminished Interleukin-6 Response to Proinflammatory Challenge in Men and Women after Intravenous Cocaine Administration
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1188 - 1193.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.